Impact of cytoreductive nephrectomy in patients with primary metastatic renal cell carcinoma receiving systemic tyrosine kinase inhibitor therapy: A multicenter retrospective study

International Journal of Urology ◽

10.1111/iju.14466 ◽

2020 ◽

Author(s):

Shingo Hatakeyama ◽

Sei Naito ◽

Kazuyuki Numakura ◽

Renpei Kato ◽

Tomoyuki Koguchi ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Retrospective Study ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Cell Carcinoma ◽

Metastatic Renal Cell Carcinoma ◽

Renal Cell ◽

Kinase Inhibitor ◽

Cytoreductive Nephrectomy ◽

Tyrosine Kinase Inhibitor Therapy

Download Full-text

Faculty Opinions recommendation of Does timing of cytoreductive nephrectomy impact patient survival with metastatic renal cell carcinoma in the tyrosine kinase inhibitor era? A multi-institutional study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717979900.793471988 ◽

2013 ◽

Author(s):

Hendrik van Poppel ◽

Yuri Tolkach

Keyword(s):

Renal Cell Carcinoma ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Cell Carcinoma ◽

Metastatic Renal Cell Carcinoma ◽

Renal Cell ◽

Kinase Inhibitor ◽

Patient Survival ◽

Cytoreductive Nephrectomy

Download Full-text

Effect of the timing of best tumor shrinkage on survival of patients with metastatic renal cell carcinoma who received first-line tyrosine kinase inhibitor therapy

International Journal of Clinical Oncology ◽

10.1007/s10147-016-1032-7 ◽

2016 ◽

Vol 22 (1) ◽

pp. 126-135 ◽

Cited By ~ 5

Author(s):

Hiroki Ishihara ◽

Takafumi Yagisawa ◽

Tsunenori Kondo ◽

Kenji Omae ◽

Toshio Takagi ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Cell Carcinoma ◽

Metastatic Renal Cell Carcinoma ◽

Renal Cell ◽

Kinase Inhibitor ◽

Tumor Shrinkage ◽

First Line ◽

Tyrosine Kinase Inhibitor Therapy

Download Full-text

MP66-02 SURVIVAL ANALYSIS OF PATIENTS WITH METASTATIC RENAL CELL CARCINOMA UNDERGOING CYTOREDUCTIVE NEPHRECTOMY WITH OR WITHOUT A NEOADJUVANT TYROSINE KINASE INHIBITOR

The Journal of Urology ◽

10.1016/j.juro.2018.02.1874 ◽

2018 ◽

Vol 199 (4S) ◽

Author(s):

Jing Zhi Lo ◽

Peter Sunaryo ◽

David Paulucci ◽

Ketan Badani

Keyword(s):

Renal Cell Carcinoma ◽

Survival Analysis ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Cell Carcinoma ◽

Metastatic Renal Cell Carcinoma ◽

Renal Cell ◽

Kinase Inhibitor ◽

Cytoreductive Nephrectomy

Download Full-text

1776 DOES TIMING OF CYTOREDUCTIVE NEPHRECTOMY IMPACT PATIENT SURVIVAL WITH METASTATIC RENAL CELL CARCINOMA IN THE TYROSINE KINASE INHIBITOR ERA?

The Journal of Urology ◽

10.1016/j.juro.2011.02.2104 ◽

2011 ◽

Vol 185 (4S) ◽

Author(s):

Sean Stroup ◽

Omer Raheem ◽

Ryan Kopp ◽

Kerrin Palazzi-Churas ◽

Reza Mehrazin ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Cell Carcinoma ◽

Metastatic Renal Cell Carcinoma ◽

Renal Cell ◽

Kinase Inhibitor ◽

Patient Survival ◽

Cytoreductive Nephrectomy

Download Full-text

A phase 2, single-arm study of ramucirumab in patients with metastatic renal cell carcinoma with disease progression on or intolerance to tyrosine kinase inhibitor therapy

Cancer ◽

10.1002/cncr.28634 ◽

2014 ◽

Vol 120 (11) ◽

pp. 1647-1655 ◽

Cited By ~ 24

Author(s):

Jorge A. Garcia ◽

Gary R. Hudes ◽

Toni K. Choueiri ◽

Walter M. Stadler ◽

Laura S. Wood ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Cell Carcinoma ◽

Disease Progression ◽

Metastatic Renal Cell Carcinoma ◽

Renal Cell ◽

Kinase Inhibitor ◽

Phase 2 ◽

Tyrosine Kinase Inhibitor Therapy

Download Full-text

MP57-14 CHANGE IN PLATELET COUNT AS A PROGNOSTIC INDICATOR FOR RESPONSE TO NEOADJUVANT TYROSINE KINASE INHIBITOR THERAPY IN METASTATIC RENAL CELL CARCINOMA

The Journal of Urology ◽

10.1016/j.juro.2014.02.1789 ◽

2014 ◽

Vol 191 (4S) ◽

Author(s):

Hak Lee ◽

Nishant Patel ◽

Ryan Kopp ◽

Michael Liss ◽

Reza Mehrazin ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Platelet Count ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Cell Carcinoma ◽

Metastatic Renal Cell Carcinoma ◽

Renal Cell ◽

Kinase Inhibitor ◽

Prognostic Indicator ◽

Tyrosine Kinase Inhibitor Therapy

Download Full-text

Does Timing of Cytoreductive Nephrectomy Impact Patient Survival With Metastatic Renal Cell Carcinoma in the Tyrosine Kinase Inhibitor Era? A Multi-institutional Study

Urology ◽

10.1016/j.urology.2012.10.054 ◽

2013 ◽

Vol 81 (4) ◽

pp. 805-812 ◽

Cited By ~ 25

Author(s):

Sean P. Stroup ◽

Omer A. Raheem ◽

Kerrin L. Palazzi ◽

Michael A. Liss ◽

Reza Mehrazin ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Cell Carcinoma ◽

Metastatic Renal Cell Carcinoma ◽

Renal Cell ◽

Kinase Inhibitor ◽

Patient Survival ◽

Cytoreductive Nephrectomy

Download Full-text

Change in platelet count as a prognostic indicator for response to primary tyrosine kinase inhibitor therapy in metastatic renal cell carcinoma

BJU International ◽

10.1111/bju.13490 ◽

2016 ◽

Vol 118 (6) ◽

pp. 927-934 ◽

Cited By ~ 4

Author(s):

Zachary Hamilton ◽

Hak J. Lee ◽

Juan Jimenez ◽

Brian R. Lane ◽

Song Wang ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Platelet Count ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Cell Carcinoma ◽

Metastatic Renal Cell Carcinoma ◽

Renal Cell ◽

Kinase Inhibitor ◽

Prognostic Indicator ◽

Tyrosine Kinase Inhibitor Therapy

Download Full-text

A Case of Metastatic Renal Cell Carcinoma to the Maxillary Sinus Treated with Tyrosine Kinase Inhibitor

Korean Journal of Otorhinolaryngology - Head and Neck Surgery ◽

10.3342/kjorl-hns.2012.55.11.717 ◽

2012 ◽

Vol 55 (11) ◽

pp. 717 ◽

Cited By ~ 2

Author(s):

Young Hyo Kim ◽

Jae Eun Kim ◽

Sungmin Park ◽

Tae Young Jang

Keyword(s):

Renal Cell Carcinoma ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Cell Carcinoma ◽

Maxillary Sinus ◽

Metastatic Renal Cell Carcinoma ◽

Renal Cell ◽

Kinase Inhibitor

Download Full-text

Long-term outcomes of tyrosine kinase inhibitor discontinuation in patients with metastatic renal cell carcinoma

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-015-2942-1 ◽

2015 ◽

Vol 77 (2) ◽

pp. 339-347 ◽

Cited By ~ 3

Author(s):

Dong-Hoe Koo ◽

Inkeun Park ◽

Jin-Hee Ahn ◽

Dae-Ho Lee ◽

Dalsan You ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Cell Carcinoma ◽

Metastatic Renal Cell Carcinoma ◽

Renal Cell ◽

Kinase Inhibitor ◽

Long Term Outcomes ◽

Tyrosine Kinase Inhibitor Discontinuation

Download Full-text